Cho YH - Search Results

1

A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS.

Ryu WJ, Lee JE, Cho YH, Lee G, Seo MK, Lee SK, Hwang JH, Min DS, Noh SH, Paik S, Kim S, Cheong JH, Choi KY. Ryu WJ, et al. Among authors: cho yh. Cancers (Basel). 2019 Apr 8;11(4):496. doi: 10.3390/cancers11040496. Cancers (Basel). 2019. PMID: 30965636 Free PMC article.

2

House dust mite allergen Der f 2 induces interleukin-13 expression by activating the PI3K/Akt pathway.

Ro EJ, Cha PH, Kim HY, Cho YH, Park JW, Han JS, Choi KY. Ro EJ, et al. Among authors: cho yh. Immunol Res. 2013 May;56(1):181-8. doi: 10.1007/s12026-013-8392-0. Immunol Res. 2013. PMID: 23564227

3

Response.

Moon BS, Cho YH, Jeong WJ, Choi KY. Moon BS, et al. Among authors: cho yh. J Natl Cancer Inst. 2014 Aug 18;106(8):dju197. doi: 10.1093/jnci/dju197. Print 2014 Aug. J Natl Cancer Inst. 2014. PMID: 25136033 No abstract available.

4

NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.

Kim KH, Kim D, Park JY, Jung HJ, Cho YH, Kim HK, Han J, Choi KY, Kwon HJ. Kim KH, et al. Among authors: cho yh. J Mol Med (Berl). 2015 May;93(5):499-509. doi: 10.1007/s00109-014-1235-1. Epub 2014 Dec 4. J Mol Med (Berl). 2015. PMID: 25471482

5

K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis.

Koo KH, Jeong WJ, Cho YH, Park JC, Min do S, Choi KY. Koo KH, et al. Among authors: cho yh. Oncotarget. 2015 Aug 28;6(25):21328-40. doi: 10.18632/oncotarget.4049. Oncotarget. 2015. PMID: 26015399 Free PMC article.

6

Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells.

Kang DW, Choi CY, Cho YH, Tian H, Di Paolo G, Choi KY, Min do S. Kang DW, et al. Among authors: cho yh. J Exp Med. 2015 Jul 27;212(8):1219-37. doi: 10.1084/jem.20141254. Epub 2015 Jun 29. J Exp Med. 2015. PMID: 26122663 Free PMC article.

7

Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation.

Cha PH, Cho YH, Lee SK, Lee J, Jeong WJ, Moon BS, Yun JH, Yang JS, Choi S, Yoon J, Kim HY, Kim MY, Kaduwal S, Lee W, Min do S, Kim H, Han G, Choi KY. Cha PH, et al. Among authors: cho yh. Nat Chem Biol. 2016 Aug;12(8):593-600. doi: 10.1038/nchembio.2103. Epub 2016 Jun 13. Nat Chem Biol. 2016. PMID: 27294323

8

KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.

Cho YH, Cha PH, Kaduwal S, Park JC, Lee SK, Yoon JS, Shin W, Kim H, Ro EJ, Koo KH, Park KS, Han G, Choi KY. Cho YH, et al. Oncotarget. 2016 Dec 6;7(49):81727-81740. doi: 10.18632/oncotarget.13172. Oncotarget. 2016. PMID: 27835580 Free PMC article.

9

Identification of Ras-degrading small molecules that inhibit the transformation of colorectal cancer cells independent of β-catenin signaling.

Shin W, Lee SK, Hwang JH, Park JC, Cho YH, Ro EJ, Song Y, Seo HR, Choi KY. Shin W, et al. Among authors: cho yh. Exp Mol Med. 2018 Jun 6;50(6):1-10. doi: 10.1038/s12276-018-0102-5. Exp Mol Med. 2018. PMID: 29884842 Free PMC article.

10

β-Catenin-RAS interaction serves as a molecular switch for RAS degradation via GSK3β.

Lee SK, Jeong WJ, Cho YH, Cha PH, Yoon JS, Ro EJ, Choi S, Oh JM, Heo Y, Kim H, Min DS, Han G, Lee W, Choi KY. Lee SK, et al. Among authors: cho yh. EMBO Rep. 2018 Dec;19(12):e46060. doi: 10.15252/embr.201846060. Epub 2018 Nov 9. EMBO Rep. 2018. PMID: 30413483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,580 results

Search Page

Filters